1. Home
  2. CRL vs PCVX Comparison

CRL vs PCVX Comparison

Compare CRL & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$214.20

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$53.81

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRL
PCVX
Founded
1947
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
7.0B
IPO Year
1999
2020

Fundamental Metrics

Financial Performance
Metric
CRL
PCVX
Price
$214.20
$53.81
Analyst Decision
Buy
Strong Buy
Analyst Count
12
4
Target Price
$198.27
$88.25
AVG Volume (30 Days)
752.4K
1.4M
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,857,601,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$3.04
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.48
N/A
52 Week Low
$144.26
$29.10
52 Week High
$228.88
$65.00

Technical Indicators

Market Signals
Indicator
CRL
PCVX
Relative Strength Index (RSI) 73.04 60.67
Support Level $193.41 $52.04
Resistance Level $228.64 $56.04
Average True Range (ATR) 7.45 2.37
MACD 2.68 0.94
Stochastic Oscillator 92.13 74.71

Price Performance

Historical Comparison
CRL
PCVX

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: